TZUNG-DAU WANG2020-12-012020-12-0120201011-6842https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084351896&doi=10.6515%2fACS.202005_36%283%29.20200430A&partnerID=40&md5=bab0f262cde747ce96b6934d40f96e81https://scholars.lib.ntu.edu.tw/handle/123456789/523286[SDGs]SDG3amino terminal pro brain natriuretic peptide; angiotensin 1 receptor; angiotensin converting enzyme 2; angiotensin II; angiotensin receptor antagonist; angiotensin[1-7]; apelin; camostat mesilate; dipeptidyl carboxypeptidase inhibitor; enkephalinase inhibitor; membrane protein; transmembrane protease serine 2; tumor necrosis factor alpha converting enzyme; unclassified drug; virus spike protein; acute lung injury; cardiovascular risk; cerebrovascular disease; coronary artery disease; coronavirus disease 2019; diabetes mellitus; Editorial; heart left ventricle ejection fraction; human; hypertension; mortality; nonhuman; prevalence; protein degradation; protein expression; renin angiotensin aldosterone system; risk factor; SARS coronavirus; Severe acute respiratory syndrome coronavirus 2; virus entry; virus sheddingeditorial10.6515/ACS.202005_36(3).20200430A2-s2.0-85084351896